Source: http://www.google.es/patents/US9101697
Timestamp: 2017-10-22 08:39:22
Document Index: 339750155

Matched Legal Cases: ['Application No. 2007', 'Application No. 2007', 'Application No. 2007', 'Application No. 2007', 'Application No. 2007', 'Application No. 2007']

Patente US9101697 - Hyaluronic acid based copolymers - Google Patentes
Hyaluronic acid (HA) conjugates or crosslinked HAs compositions for coating an implantable device are provided. The implantable device can be used for treating a disorder such as atherosclerosis, thrombosis, restenosis, high cholesterol, hemorrhage, vascular dissection or perforation, vascular aneurysm,...http://www.google.es/patents/US9101697?utm_source=gb-gplus-sharePatente US9101697 - Hyaluronic acid based copolymers
Número de publicación US9101697 B2
Número de solicitud US 14/251,489
También publicado como EP1750783A2, US8293890, US8734817, US8846836, US8906394, US20050244363, US20130023507, US20130023508, US20130023509, US20140221418, WO2005110505A2, WO2005110505A3
Número de publicación 14251489, 251489, US 9101697 B2, US 9101697B2, US-B2-9101697, US9101697 B2, US9101697B2
Inventores Syed Faiyaz Ahmed Hossainy, Eugene Michal, Thierry Glauser, Connie Kwok, Stephen Dirk Pacetti
Citas de patentes (429), Otras citas (73), Clasificaciones (16)
US 9101697 B2
US3839309 2 Oct 1972 1 Oct 1974 Owens Illinois Inc Polyacrylamide derivatives and method of insolubilizing enzymes therewith
US4956489 14 Oct 1988 11 Sep 1990 Bioeurope Water-soluble L-tyrosine derivatives and a process for preparing L-tyrosine derivatives
US5026821 2 Mar 1989 25 Jun 1991 Sanofi Polymers of citric acid and diamines, a process for their preparation and their uses, in particular as carriers of drugs
US5214112 * 6 Sep 1990 25 May 1993 Shin-Etsu Chemical Co., Ltd. Method of preventing polymer deposition and polymer scale preventive agent
US5316912 13 Dic 1989 31 May 1994 Urs Heimgartner Polyacrylic hydrazides and their applications as glycoprotein reagents
US5652347 7 Jun 1995 29 Jul 1997 The Research Foundation Of State University Of New York Method for making functionalized derivatives of hyaluronic acid
US5690961 22 Dic 1994 25 Nov 1997 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5770637 1 May 1996 23 Jun 1998 Johnson & Johnson Vision Products, Inc. Anti-bacterial, UV absorbable, tinted, metal-chelating polymers
US5849368 5 May 1997 15 Dic 1998 Schneider (Usa) Inc Process for hydrophilicization of hydrophobic polymers
US6261544 15 Feb 1999 17 Jul 2001 Focal, Inc. Poly(hydroxy acid)/polymer conjugates for skin applications
US6534560 20 Sep 2001 18 Mar 2003 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
US7091191 19 Dic 2003 15 Ago 2006 Ethicon, Inc. Modified hyaluronic acid for use in musculoskeletal tissue repair
US7202064 20 Jun 2003 10 Abr 2007 Metabolix, Inc. Polyhydroxyalkanoate biopolymer compositions
US7368169 1 Dic 2004 6 May 2008 Rutgers, The State University Of New Jersey Hydrazide compounds with angiogenic activity
US20020049281 2 Ago 2001 25 Abr 2002 Xiaobin Zhao Process for cross-linking hyaluronic acid to polymers
US20020183858 5 Jun 2001 5 Dic 2002 Contiliano Joseph H. Attachment of absorbable tissue scaffolds to scaffold fixation devices
US20030012765 17 Sep 2001 16 Ene 2003 Thompson Andrea Y. Cross-linked polysaccharide drug carrier
US20030050422 29 Mar 2002 13 Mar 2003 Isotis N.V. Poly (ether ester amide) and poly (ether ester urethane) copolymers
US20030059463 7 Dic 2000 27 Mar 2003 Mika Lahtinen Medical device
US20030100937 21 Nov 2002 29 May 2003 Fuminori Tsuboi Implantable electrode lead
US20030195610 4 Abr 2002 16 Oct 2003 Herrmann Robert A. Processes for producing polymer coatings through surface polymerization
US20030208258 2 May 2002 6 Nov 2003 Tom Reilly Vascular grafts surrounding an expanded stent for transplantation
US20030216758 27 Dic 2002 20 Nov 2003 Angiotech Pharmaceuticals, Inc. Coated surgical patches
US20040010048 15 Ago 2002 15 Ene 2004 Evans Douglas G. Resorbable structure for treating and healing of tissue defects
US20050089970 12 Jul 2001 28 Abr 2005 Bradburne James A. Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
US20050147642 19 Dic 2003 7 Jul 2005 Laredo Walter R. Tissue scaffolds for use in muscoloskeletal repairs
EP1270018B1 28 Jun 2002 13 Abr 2005 Ethicon Inc. Sterilization of bioactive coatings
JP2002085549A Título no disponible
JP2003524465A Título no disponible
JPH0959303A Título no disponible
JPH08333402A Título no disponible
JPH10506560A Título no disponible
JPS63105003U Título no disponible
WO1999010385A1 7 Ago 1998 4 Mar 1999 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, process for producing the same and medical material containing the same
WO2000041739A1 14 Ene 2000 20 Jul 2000 University Of Utah Research Foundation Attachment of acid moiety-containing biomolecules to activated polymeric surfaces
WO2001093846A3 23 May 2001 23 May 2002 Exhale Therapeutics Inc Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans
WO2002006373A1 * 17 Jul 2001 24 Ene 2002 University Of Utah Research Foundation Hydrogel films and methods of making and using therefor
WO2002034312A1 3 Nov 2000 2 May 2002 Mediplex Corp., Korea Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
1 Anonymous, Cardiologists Draw-Up the Dream Stent, Clinica 710:15 (Jun. 17, 1996), http://www.dialogweb.com/cgi/document?req=1061848202959, printed Aug. 25, 2003, 2 pages.
8 Bullesfeld et al., "Long term evaluation of paclitaxel-coated stents for treatment of native coronary lesions", Z. Kardiol. 92, pp. 825-832 (2003).
9 Bulpitt et al., Journal of Biomedical Materials Research 1999, 47:152-169.
10 Chen et al. Journal of Biomedical Materials Research 2002 61:360-369.
12 Clark, "Reduction of Carboxylic Acids," www.chemguide.com.uk/organicprops/acids/reduction.html, 3 pgs (2004).
13 Decision of Refusal dated Dec. 11, 2012 for Japanese Patent Application No. 2007-510975, 2 pp.
17 Gianolio et al. "Cross-Linked Hyaluronan Containing Labile Linkages," Society for Biomaterials, 2002, 1 pp.
18 Grinstaff et al. "Photocrosslinkable polysaccharides for in situ bydrogel formation," J. of Biomed. Mat. Res. vol. 54, No. 1, pp. 115-121 (2001).
19 Grinstaff et al., "Photocrosslinkable polymers for biomedical applications", Polymer Preprints 42(2), pp. 101-102 (2001).
20 Grube et al., "Safety and Performance of a Pacilitaxel-Eluting Stent for the Treatment of in-Stent Restenosis: Preliminary Results of the Taxus III Trial", J. of Am. Coll. of Cardiology 39, Abstract 1 pg. (2002).
21 Grube et al., "Six-and Twelve-Month Results from a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions", Circulation 107, pp. 38-42 (2003).
22 Hamad et al. Molecules 20005:895-907.
23 Helmus, Overview of Biomedical Materials, MRS Bulletin, pp. 33-38 (Sep. 1991).
24 Herdeg et al., Antiproliferative Stent Coatings: Taxol and Related Compounds, Semin. Intervent. Cardiol. 3:197-199 (1998).
26 Hwang et al., "Physiological Transport Forces Govern Drug Distribution for Stent-Based Delivery", Circulation 104, pp. 600-605 (2001).
28 International Search Report for PCT/US2005/014614 filed Apr. 27, 2005, mailed May 18, 2006, 17 pgs.
29 Jai et al. Macromolecules, 2004, 37:3239-3248.
33 Kim et al. Biomaterials 2003 24: 4671-4679.
34 Kirker et al. Biomaterials 2002 23:3661-3671.
35 Lambert et al., "Localized Arterial Wall Drug Delivery From a Polymer-Coated Removable Metallic Stent", Circulation vol. 90, issue 2, pp. 1003-1011(1994).
36 Leach et al. Biotechnology and Bioengineering, 2003 82:578-589.
37 Levy et al., Strategies For Treating Arterial Restenosis Using Polymeric Controlled Release Implants, Biotechnol. Bioact. Polym. [Proc. Am. Chem. Soc. Symp.], pp. 259-268 (1994).
38 Lincoff et al., "Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model", JACC vol. 29, No. 4, pp. 808-816 (1997).
39 Liu et al., Drug release characteristics of unimolecular polymeric micelles, Journal of Controlled Release 68:167-174 (2000).
40 Liu et at., Advances in Polymer Technology 1992, 11:249-262.
41 Luo et al. "Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery," Journal of Controlled Release, 2000, vol. 69, pp. 169-184.
42 Luo et al. Journal of Controlled Release 2000 69:169-184.
43 Luo et al., "Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery", J. of Controlled Release 69, pp. 169-184 (2000).
44 Marconi et al., Covalent bonding of heparin to a vinyl copolymer for biomedical applications, Biomaterials 18(12):885-890 (1997).
45 Matsumaru et al., Embolic Materials for Endovascular Treatment of Cerebral Lesions, J. Biomater. Sci. Polymer Edn 8(7):555-569 (1997).
46 Miyazaki et al., Antitumor Effect of Implanted Ethylene-Vinyl Alcohol Copolymer Matrices Containing Anticancer Agents on Ehrlich Ascites Carcinoma and P388 Leukemia in Mice, Chem. Pharm. Bull. 33(6) 2490-2498 (1985).
47 Miyazawa et al., Effects of Pemirolast and Tranilast on Intimal Thickening After Arterial Injury in the Rat, J. Cardiovasc. Pharmacol., pp. 157-162 (1997).
48 Moriyama et al. Journal of Controlled Release 1999 59:77-86.
49 Nordrehaug et al., A novel biocompatible coating applied to coronary stents, European Heart Journal 14, p. 321 (P1694), Abstr. Suppl. (1993).
50 Notification of Reasons for Refusal with partial translation dated Jul. 8, 2014 for Japanese Patent Application No. 2007-510975, 30 pp.
51 Notification of Reasons for Refusal with partial translation dated Nov. 8, 2011 for Japanese Patent Application No. 2007-510975, 5 pp.
52 Ohsawa et al., Preventive Effects of an Antiallergic Drug, Pemirolast Potassium, on Restenosis After Percutaneous Transluminal Coronary Angioplasty, American Heart Journal 136(6):1081-1087 (Dec. 1998).
53 Organics Synthesis II: Alcohol and Amine, Jikken Kagaku Kouza, 4th ed., The 4th series of Experimental Chemistry, The Chemical Society of Japan Ed., 1992, pp. 300-302.
54 Ozaki et al., New Stent Technologies, Progress in Cardiovascular Diseases, vol. XXXIX(2):129-140 (Sep./Oct. 1996).
55 Pechar et al., Poly(ethylene glycol) Multiblock Copolymer as a Carrier of Anti-Cancer Drug Doxorubicin, Bioconjucate Chemistry 11(2):131-139 (Mar./Apr. 2000).
56 Peng et al., Role of polymers in improving the results of stenting in coronary arteries, Biomaterials 17:685694 (1996).
57 Prestwich et al. Journal of Cotrolled Release 1998 53:93-103.
58 Raddatz Necleic Acid Research 2002 30:4793-4802.
59 Saotome, et al., Novel Enzymatically Degradable Polymers Comprising alpha-Amino Acid, 1,2-Ethanediol, and Adipic Acid, Chemistry Letters, pp. 21-24, (1991).
60 Saotome, et al., Novel Enzymatically Degradable Polymers Comprising α-Amino Acid, 1,2-Ethanediol, and Adipic Acid, Chemistry Letters, pp. 21-24, (1991).
61 Shigeno, Prevention of Cerebrovascular Spasm by Bosentan, Novel Endothelin Receptor, Chemical Abstract 125:212307 (1996).
62 Smeds et al., "Photocrosslinkable polysaccharides for in situ hydrogel formation", J. of Biomed. Mat. Res. vol. 54, No. 1, pp. 115-121 (2001).
63 Sousa et al., New frontiers in cardiology Drug-eluting stents: part I. Circulation 2003, 107: 2274-2279.
64 Tanabe et al., "In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation", Circulation 107, pp. 559-564 (2003).
65 Translation of Notification of Reasons for Refusal dated Jul. 8, 2014 for Japanese Patent Application No. 2007-510975, 31 pp.
66 Translation of Notification of Reasons for Refusal with partial translation dated Nov. 8, 2011 for Japanese Patent Application No. 2007-510975, 5 pp.
67 Translation of Notification of Refusal from JPO for appl. No. 20078-510975, mailed Nov. 8, 2011, 5 pgs.
68 Translation of the Decision of Refusal dated Dec. 11, 2012 for Japanese Patent Application No. 2007-510975, 5 pp.
69 van Beusekom et al., Coronary stent coatings, Coronary Artery Disease 5(7):590-596 (Jul. 1994).
70 Van Der Giesen et al. "Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries", Circulation vol. 94, issue 7, pp. 1690-1697 (1996).
73 Yoshida et al. "Convenient synthesis of polymers containing terminal aldehyde and ketone moieties by selective oxidation of polymeric terminal diols with an oxoaminium salt," Makromolecular Chemistry 194: pp. 2507-2515 (1993).
Clasificación internacional A61L31/10, C08G63/48, A61L31/16, A61L27/00, A61K31/727, A61K31/785, A61K31/44, A61K31/728
Clasificación cooperativa A61K31/728, A61L31/16, A61K31/785, A61K31/727, A61L31/10, C08L5/08, A61K2300/00, C08L5/10